Sprint Precision Technologies
688605
Jiangsu Jingxue Insulation Technology
301010
Global Infotech
300465
Hydsoft Technology
301316
SGSG Science&Technology
300561
CN Stock MarketDetailed Quotes
688273 Nanjing Medlander Medical Technology
- 26.40
- +0.35+1.34%
Market Closed Dec 12 15:00 CST
2.64BMarket Cap26.09P/E (TTM)
26.40High26.00Low8.02KlotVolume26.00Open26.05Pre Close21.05MTurnover2.18%Turnover Ratio29.40P/E (Static)100.00MShares32.6252wk High2.02P/B972.23MFloat Cap16.6652wk Low31.26Limit Up36.83MShs Float48.30Historical High20.84Limit Down1.54%Amplitude16.66Historical Low1.00Dividend TTM26.25Avg Price3.25KlotAsk3.79%Div YieldTTM100Lot Size4.42KlotBid
Nanjing Medlander Medical Technology Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 13.81%330.58M | 11.73%228.38M | -4.39%104.34M | -9.57%340.82M | -2.64%290.46M | 11.61%204.4M | 46.34%109.12M | 10.32%376.89M | 29.36%298.32M | 18.83%183.13M |
| Operating revenue | 13.81%330.58M | 11.73%228.38M | -4.39%104.34M | -9.57%340.82M | -2.64%290.46M | 11.61%204.4M | 46.34%109.12M | 10.32%376.89M | 29.36%298.32M | 18.83%183.13M |
| Total operating cost | 5.34%232.3M | -2.64%153.78M | -15.24%67.44M | 1.14%275.11M | 4.06%220.53M | 14.09%157.96M | 50.40%79.57M | 15.15%272.01M | 35.53%211.92M | 36.06%138.45M |
| Operating cost | 6.83%91.4M | -4.79%61.66M | -32.73%27.07M | -16.93%98.47M | -13.23%85.56M | -4.83%64.77M | 100.86%40.24M | 28.15%118.53M | 60.09%98.61M | 71.31%68.06M |
| Operating tax surcharges | -14.87%3.07M | -22.89%2.06M | -52.77%519.22K | 16.44%4.95M | 23.00%3.61M | 45.67%2.68M | 27.52%1.1M | -13.86%4.25M | -14.60%2.93M | -32.15%1.84M |
| Operating expense | 0.26%66.28M | 0.44%44.46M | 3.46%19.82M | -1.92%82.53M | 6.41%66.11M | 15.69%44.27M | 9.35%19.15M | 14.11%84.14M | 33.23%62.13M | 27.73%38.26M |
| Administration expense | 15.35%38.26M | 11.70%25.25M | 10.81%10.89M | 38.51%45.31M | 44.82%33.17M | 63.14%22.6M | 48.67%9.82M | 15.10%32.72M | 17.31%22.91M | 10.16%13.85M |
| Financial expense | 31.99%-7.33M | -17.57%-6.07M | -32.26%-3.8M | -60.54%-14.38M | -310.31%-10.78M | -201.60%-5.16M | -317.58%-2.87M | -1,406.77%-8.96M | -560.05%-2.63M | -297,565.44%-1.71M |
| -Interest expense (Financial expense) | 142.89%763.43K | 107.29%443.7K | 66.73%182.54K | 26.59%380.94K | 67.33%314.31K | 65.81%214.04K | 68.75%109.48K | 97.07%300.94K | -6.88%187.84K | 13.53%129.09K |
| -Interest Income (Financial expense) | 27.01%-8.13M | -21.24%-6.52M | -32.72%-3.99M | -59.75%-14.87M | -377.79%-11.14M | -190.50%-5.38M | -295.70%-3M | -1,092.45%-9.31M | -272.00%-2.33M | -1,293.77%-1.85M |
| Research and development | -5.23%40.62M | -8.29%26.42M | 6.78%12.95M | 40.89%58.24M | 53.18%42.86M | 58.75%28.81M | 41.40%12.13M | 11.04%41.34M | 9.38%27.98M | 8.10%18.15M |
| Credit Impairment Loss | -351.82%-853.14K | -658.02%-998.86K | -116.32%-433K | 77.81%-647.63K | 85.09%-188.82K | 88.05%-131.77K | -43.99%-200.17K | -437.71%-2.92M | -630.82%-1.27M | -819.01%-1.1M |
| Asset Impairment Loss | ---- | ---- | ---- | -31.11%-457.18K | ---- | ---- | ---- | -106.15%-348.71K | ---- | ---- |
| Other net revenue | ||||||||||
| Fair value change income | 219.71%1.13M | 37.29%496.15K | ---340.05K | --652.16K | --352.12K | 157.93%361.39K | ---- | ---- | ---- | --140.11K |
| Invest income | -79.56%2.17M | -80.38%1.61M | -71.76%1.36M | 74.28%13.89M | 158.63%10.63M | 532.57%8.19M | 1,108.21%4.82M | 67.17%7.97M | 134.54%4.11M | -21.85%1.3M |
| -Including: Investment income associates | -60.48%-495.23K | -0.75%-217.1K | 26.95%-104.45K | -903.44%-344.22K | -366.39%-308.6K | -240.61%-215.49K | -305.34%-142.99K | 37.37%42.84K | -90.91%-66.17K | -195.04%-63.27K |
| Asset deal income | -6,751.93%-248.24K | ---- | ---- | --234.85K | --3.73K | ---- | ---- | ---- | ---- | 238.06%842.15 |
| Other revenue | -23.77%12.9M | -18.71%9.68M | 25.69%4.56M | -36.33%23.1M | -41.00%16.92M | 0.24%11.91M | 36.79%3.63M | 79.36%36.28M | 96.00%28.68M | 3.39%11.88M |
| Operating profit | 16.11%113.37M | 27.87%85.39M | 11.23%42.05M | -29.74%102.48M | -17.20%97.64M | 17.35%66.78M | 53.81%37.8M | 12.19%145.86M | 28.52%117.92M | -12.74%56.91M |
| Add:Non operating Income | 93.49%156.61K | 2.22%61.25K | -17.92%10.99K | -15.66%91.76K | -13.94%80.94K | -20.47%59.92K | -55.15%13.39K | 709.47%108.8K | 599.80%94.06K | 595.03%75.34K |
| Less:Non operating expense | 53.20%466.77K | 48.80%223.12K | -99.41%34.66 | 1,458.28%1.1M | 4,156.15%304.67K | 1,284.89%149.94K | 181.39%5.86K | -75.78%70.28K | -97.43%7.16K | -95.89%10.83K |
| Total profit | 16.06%113.06M | 27.80%85.23M | 11.23%42.06M | -30.44%101.48M | -17.45%97.42M | 17.06%66.69M | 53.67%37.81M | 12.46%145.9M | 28.99%118M | -12.30%56.97M |
| Less:Income tax cost | 15.54%12.53M | 54.64%9.32M | -12.36%3.87M | -45.83%9M | -8.09%10.85M | 7.31%6.03M | 111.71%4.42M | 65.47%16.61M | -10.70%11.8M | -41.48%5.62M |
| Net profit | 16.13%100.53M | 25.13%75.91M | 14.36%38.19M | -28.47%92.48M | -18.49%86.57M | 18.13%60.66M | 48.29%33.39M | 8.01%129.29M | 35.69%106.2M | -7.25%51.35M |
| Net profit from continuing operation | 16.13%100.53M | 25.13%75.91M | 14.36%38.19M | -28.47%92.48M | -18.49%86.57M | 18.13%60.66M | 48.29%33.39M | 8.01%129.29M | 35.69%106.2M | -7.25%51.35M |
| Less:Minority Profit | 143.46%4.46M | 81.51%3.3M | 88.74%1.9M | -64.93%2.67M | -77.41%1.83M | -61.13%1.82M | -29.76%1.01M | 478.51%7.6M | 1,016.57%8.11M | 4,917.10%4.68M |
| Net profit of parent company owners | 13.37%96.07M | 23.39%72.61M | 12.04%36.29M | -26.19%89.82M | -13.62%84.74M | 26.08%58.84M | 53.60%32.39M | 2.79%121.68M | 26.51%98.1M | -15.56%46.67M |
| Earning per share | ||||||||||
| Basic earning per share | 15.19%0.9728 | 24.97%0.7331 | 13.00%0.366 | -38.49%0.8982 | -33.04%0.8445 | -5.74%0.5866 | 15.23%0.3239 | -7.49%1.4602 | 21.98%1.2612 | -15.56%0.6223 |
| Diluted earning per share | 15.19%0.9728 | 24.97%0.7331 | 13.00%0.366 | -38.49%0.8982 | -33.04%0.8445 | -5.74%0.5866 | 15.23%0.3239 | -7.49%1.4602 | 21.98%1.2612 | -15.56%0.6223 |
| Other composite income | ||||||||||
| Total composite income | 16.13%100.53M | 25.13%75.91M | 14.36%38.19M | -28.47%92.48M | -18.49%86.57M | 18.13%60.66M | 48.29%33.39M | 8.01%129.29M | 35.69%106.2M | -7.25%51.35M |
| Total composite income of parent company owners | 13.37%96.07M | 23.39%72.61M | 12.04%36.29M | -26.19%89.82M | -13.62%84.74M | 26.08%58.84M | 53.60%32.39M | 2.79%121.68M | 26.51%98.1M | -15.56%46.67M |
| Total composite income of minority owners | 143.46%4.46M | 81.51%3.3M | 88.74%1.9M | -64.93%2.67M | -77.41%1.83M | -61.13%1.82M | -29.76%1.01M | 478.51%7.6M | 1,016.57%8.11M | 4,917.10%4.68M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | -- | -- | -- |
| Auditor | -- | -- | -- | Tianheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianheng Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
